Silver Oak Securities’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.65M Buy
7,340
+457
+7% +$114K 0.12% 175
2025
Q4
$1.67M Buy
6,883
+199
+3% +$50.9K 0.11% 184
2025
Q3
$1.83M Buy
6,684
+1,453
+28% +$397K 0.14% 155
2025
Q2
$1.35M Buy
5,231
+364
+7% +$86.8K 0.11% 195
2025
Q1
$1.07M Sell
4,867
-675
-12% -$158K 0.1% 223
2024
Q4
$1.27M Buy
5,542
+709
+15% +$171K 0.12% 180
2024
Q3
$1.16M Buy
4,833
+4,748
+5,586% +$1.06M 0.12% 181
2024
Q2
$16.3K Buy
+85
New +$17.2K ﹤0.01% 467

Other funds holding RMD

Silver Oak Securities's RMD Position: Q1 2026 in Review

Silver Oak Securities increased its ResMed (RMD) stake by 6.6% in Q1 2026, buying an estimated $114K and bringing the position to 7,340 shares worth $1.65M. The position accounts for 0.12% of the portfolio, ranked #175.

Silver Oak Securities first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.83M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Silver Oak Securities held 7,340 shares of ResMed worth $1.65M as of Q1 2026.
  • Silver Oak Securities bought 457 ResMed shares in Q1 2026, an estimated $114K.
  • ResMed made up 0.12% of Silver Oak Securities's portfolio in Q1 2026, its #175 holding.
  • Silver Oak Securities first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
  • Silver Oak Securities's ResMed position peaked at $1.83M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Silver Oak Securities's 13F filing for Q1 2026, filed 20 Apr 2026.